Cancer genome and Immune system regulation

Our lab focuses on integrating computational and experimental approaches to study genome regulation in cancer and immune diseases. We develop new biological assays and computational models to identify novel pathways, new host-pathogen interactions and regulatory noncoding RNAs (e.g. enhancer RNAs and circular RNAs) that could trigger disease. 

We are particularly interested in exploiting existing high throughput sequencing data (e.g. RNA-seq, ChIP-seq, ATAC-seq) to guide our hypothesis and experiments.